查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813809

全球介入性心臟病学设备市场：市场规模、份额、趋势分析（按产品和地区）、细分市场预测（2025-2033）

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

介入性心臟病学设备市场摘要

2024 年全球介入性心臟病设备市场价值估计为 105.7 亿美元，预计到 2033 年将达到 197.5 亿美元，2025 年至 2033 年的复合年增长率为 7.25%。

市场成长的动力包括心血管疾病盛行率的上升、对微创手术的需求的增加以及药物释放型支架和生物可吸收血管支架等技术的进步。

老年人口的不断增长、医疗支出的不断增加以及新兴市场心臟护理服务可近性的改善也促进了市场扩张。产品创新以及人工智慧和影像技术在导管介入治疗中的整合进一步推动了需求。心血管疾病盛行率的上升是主要的市场驱动力。久坐不动的生活方式、不良的饮食习惯以及肥胖和糖尿病发病率的上升导致全球冠状动脉疾病和其他心臟疾病的发病率激增。日益加重的疾病负担推动了对及时有效干预措施的需求，从而推动了支架、导管和其他介入工具的采用。

2024年10月，美国疾病管制与预防中心（CDC）报告称，心臟病仍然是美国的主要死因，2023年导致超过91.9万人死亡，占总死亡人数的近三分之一。心血管疾病每34秒就会造成一人死亡，约5%的成年人罹患冠状动脉疾病。 2020年至2021年，心臟病对美国经济造成的医疗费用、药物费用和生产力损失高达4,179亿美元。

目录

第一章 分析方法与范围

第二章执行摘要

3.介入性心臟病学设备市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 介入性心臟病学设备市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
  • 技术状况
  • 案例研究分析

4. 全球介入性心臟病学设备市场分析（依产品划分）（2021-2033）

  • 定义和范围
  • 按产品分類的市占率分析（2024 年和 2033 年）
  • 细分仪表板
  • 全球介入性心臟病学设备市场（依产品划分）（2021-2033）
  • 冠状动脉支架
    • 冠状动脉支架市场估计与预测（2021-2033）
    • DES
    • BMS
    • BRS
  • PTCA球囊导管
    • PTCA球囊导管市场估计与预测（2021-2033）
    • 通常
    • 特别的
    • 药物包衣
  • 血管内成像导管和压力导管导引线
    • 血管内成像导管和压力导管导引线市场估计和预测（2021-2033）
  • 附属设备
    • 配件设备市场估计与预测（2021-2033）
    • PTCA导管导引线
    • PTCA引导管
    • 导引鞘

5. 介入性心臟病学设备市场按地区分析（2021-2033）

  • 各地区市占率分析（2024 年及 2034 年）
  • 市场仪表板：按地区
  • 市场概述：按地区
  • 介入性心臟病学设备市场份额（按地区划分）（2024 年和 2033 年）
  • 北美洲
    • 北美介入性心臟病学设备市场（2021-2033）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲介入性心臟病学设备市场（2021-2033）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司简介
    • Abbott
    • Medtronic plc
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Koninklijke Philips NV
    • Terumo Corporation
    • Alvimedica Medical Technologies Inc.
    • Teleflex Incorporated
    • B. Braun Melsungen AG
    • Biosensors International Group, Ltd.
    • Meril Life Sciences Pvt. Ltd.
    • BIOTRONIK SE &Co. KG.
    • ACIST Medical Systems, Inc.
    • Asahi Intecc Co., Ltd.
    • Cook Medical LLC
    • Medinol Ltd.
    • Merit Medical Systems, Inc.
    • NuMED, Inc.
    • OpSens Inc.
    • Zeon Medical Inc.
Product Code: 978-1-68038-122-1

Interventional Cardiology Devices Market Summary

The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market growth is driven by the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, and technological advancements such as drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets also contribute to market expansion. Product innovation and integration of AI and imaging in catheter-based interventions further fuel demand. The rising prevalence of cardiovascular diseases is a primary market driver. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.

In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease incurred a financial toll of USD 417.9 billion in healthcare costs, medications, and lost productivity.

Global Interventional Cardiology Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2021-2033. For this study, Grand View Research, Inc. has segmented the global Interventional cardiology devices market report based on product and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Stents
    • DES
    • BMS
    • BRS
  • PTCA Balloon Catheters
  • Normal
  • Specialty
  • Drug-Coated
  • Intravascular Imaging Catheters and Pressure Guidewires
  • Accessory Devices
    • PTCA Guidewires
    • PTCA Guiding Catheters
    • Introducer Sheaths
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
  • 2.3. Competitive Insights

Chapter 3. Global Interventional Cardiology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Interventional Cardiology Devices: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Interventional Cardiology Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Interventional Cardiology Devices Market, by Product, 2021 - 2033
  • 4.5. Coronary Stents
    • 4.5.1. Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. DES
      • 4.5.2.1. DES market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. BMS
      • 4.5.3.1. BMS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. BRS
      • 4.5.4.1. BRS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. PTCA Balloon Catheters
    • 4.6.1. PTCA balloon catheters market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Normal
      • 4.6.2.1. Normal market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Specialty
      • 4.6.3.1. Specialty market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Drug-Coated
      • 4.6.4.1. Drug-coated market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Intravascular Imaging Catheters and Pressure Guidewires
    • 4.7.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Accessory devices
    • 4.8.1. Accessory devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. PTCA Guidewires
      • 4.8.2.1. PTCA guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3. PTCA Guiding Catheters
      • 4.8.3.1. PTCA guiding catheters market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.4. Introducer Sheaths
      • 4.8.4.1. Introducer sheaths market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Interventional Cardiology Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2034
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Interventional Cardiology Devices Market Share by Region, 2024 & 2033:
  • 5.5. North America
    • 5.5.1. North America Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Scenario
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. U.S. Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Scenario
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Canada Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Scenario
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Mexico Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Scenario
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. UK Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Scenario
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Germany Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Scenario
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. France Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Scenario
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Italy Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Scenario
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Spain Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Scenario
      • 5.6.7.3. Competitive Scenario
      • 5.6.7.4. Norway Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Regulatory Scenario
      • 5.6.8.3. Competitive Scenario
      • 5.6.8.4. Sweden Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Regulatory Scenario
      • 5.6.9.3. Competitive Scenario
      • 5.6.9.4. Denmark Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key Country Dynamics
      • 5.7.1.2. Regulatory Scenario
      • 5.7.1.3. Competitive Scenario
      • 5.7.1.4. Japan Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Scenario
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. China Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Scenario
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. India Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Regulatory Scenario
      • 5.7.4.3. Competitive Scenario
      • 5.7.4.4. Australia Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Regulatory Scenario
      • 5.7.5.3. Competitive Scenario
      • 5.7.5.4. South Korea Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Regulatory Scenario
      • 5.7.6.3. Competitive Scenario
      • 5.7.6.4. Thailand Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key Country Dynamics
      • 5.8.1.2. Regulatory Scenario
      • 5.8.1.3. Competitive Scenario
      • 5.8.1.4. Brazil Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Scenario
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. Argentina Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key Country Dynamics
      • 5.9.1.2. Regulatory Scenario
      • 5.9.1.3. Competitive Scenario
      • 5.9.1.4. South Africa Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Regulatory Scenario
      • 5.9.2.3. Competitive Scenario
      • 5.9.2.4. Saudi Arabia Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Regulatory Scenario
      • 5.9.3.3. Competitive Scenario
      • 5.9.3.4. UAE Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Regulatory Scenario
      • 5.9.4.3. Competitive Scenario
      • 5.9.4.4. Kuwait Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Profiles
    • 6.3.1. Abbott
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Product benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Medtronic plc
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Product benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Boston Scientific Corporation
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Product benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Cardinal Health, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Koninklijke Philips N.V.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Terumo Corporation
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Alvimedica Medical Technologies Inc.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Teleflex Incorporated
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. B. Braun Melsungen AG
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Biosensors International Group, Ltd.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Meril Life Sciences Pvt. Ltd.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. BIOTRONIK SE & Co. KG.
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. ACIST Medical Systems, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. Asahi Intecc Co., Ltd.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Cook Medical LLC
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. Medinol Ltd.
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives
    • 6.3.17. Merit Medical Systems, Inc.
      • 6.3.17.1. Company overview
      • 6.3.17.2. Financial performance
      • 6.3.17.3. Product benchmarking
      • 6.3.17.4. Strategic initiatives
    • 6.3.18. NuMED, Inc.
      • 6.3.18.1. Company overview
      • 6.3.18.2. Financial performance
      • 6.3.18.3. Product benchmarking
      • 6.3.18.4. Strategic initiatives
    • 6.3.19. OpSens Inc.
      • 6.3.19.1. Company overview
      • 6.3.19.2. Financial performance
      • 6.3.19.3. Product benchmarking
      • 6.3.19.4. Strategic initiatives
    • 6.3.20. Zeon Medical Inc.
      • 6.3.20.1. Company overview
      • 6.3.20.2. Financial performance
      • 6.3.20.3. Product benchmarking
      • 6.3.20.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 5 Canada Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 6 Mexico Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 7 Europe Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 8 UK Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 9 Germany Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 10 France Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 11 Italy Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 12 Spain Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 13 Sweden Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 14 Denmark Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 15 Norway Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 16 Asia Pacific Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 17 Japan Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 18 China Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 19 India Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 20 Australia Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 21 South Korea Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 22 Thailand Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 23 Latin America Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 24 Brazil Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 25 Argentina Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 26 MEA Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 27 South Africa Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 28 Saudi Arabia Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 29 UAE Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 30 Kuwait Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Interventional cardiology devices: market outlook
  • Fig. 9 Interventional cardiology devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Interventional cardiology devices driver impact
  • Fig. 13 Interventional cardiology devices restraint impact
  • Fig. 14 Interventional cardiology devices strategic initiatives analysis
  • Fig. 15 Interventional cardiology devices: Product movement analysis
  • Fig. 16 Interventional cardiology devices: Product outlook and key takeaways
  • Fig. 17 Coronary stents market estimates and forecasts, 2021 - 2033
  • Fig. 18 DES market estimates and forecasts, 2021 - 2033
  • Fig. 19 BMS market estimates and forecasts, 2021 - 2033
  • Fig. 20 BRS market estimates and forecasts, 2021 - 2033
  • Fig. 21 PTCA balloon catheters market estimates and forecasts, 2021 - 2033
  • Fig. 22 Normal market estimates and forecasts, 2021 - 2033
  • Fig. 23 Specialty market estimates and forecasts, 2021 - 2033
  • Fig. 24 Drug-coated market estimates and forecasts, 2021 - 2033
  • Fig. 25 Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 - 2033
  • Fig. 26 Accessory devices market estimates and forecasts, 2021 - 2033
  • Fig. 27 PTCA guidewires market estimates and forecasts, 2021 - 2033
  • Fig. 28 PTCA guiding catheters market estimates and forecasts, 2021 - 2033
  • Fig. 29 Introducer sheaths market estimates and forecasts, 2021 - 2033
  • Fig. 30 Global Interventional cardiology devices market: Regional movement analysis
  • Fig. 31 Global Interventional cardiology devices market: Regional outlook and key takeaways
  • Fig. 32 North America Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Europe Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 France Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Asia Pacific Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Latin America Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 MEA Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)